CORE--ELISA MICROARRAY FACILITY
核心--ELISA 微阵列设备
基本信息
- 批准号:7637343
- 负责人:
- 金额:$ 11.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-10 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntigensBiological AssayBiological MarkersClinicalDNA Microarray ChipDNA Microarray formatDataDoseEnvironmental ExposureEnzyme-Linked Immunosorbent AssayExposure toHumanInflammationInflammatory ResponseKnowledgeLipopolysaccharidesMonitorMusNitratesNumbersOxidative StressParaquatPlasmaProteinsProteomicsPurposeReagentSamplingScreening procedureSet proteinSideSiteSmokeSmokerSourceStandards of Weights and MeasuresStimulusStreamSystemTestingToxic effectTranslatingcigarette smokingenvironmental agentenvironmental stressorinstrumentnitratenovelprogramsresearch clinical testingresponsesensor
项目摘要
Increased oxidative stress and inflammatory responses are common effects of exposure to environmental
agents. There are many putative protein markers of environmental insult, although there is limited
knowledge of the usefulness of these proteins for monitoring low-dose exposures in humans. In addition to
putative protein markers, the proteomic and DNA microarray analyses proposed in Projects 1 and 2 are
expected to identify new candidate biomarkers for exposure to side-stream smoke. The purpose of this
ELISA microarray core is to evaluate the usefulness of candidate protein biomarkers for assessing
environmental exposures. For Project 1, we will screen -50 proteins in -120 human plasma samples to
identify proteins that are altered in response to cigarette smoke. Although most of these analyses will be
undertaken using commercial reagents, this core will also develop sandwich ELISA's for up to 10 biomarkers
for which commercial assays are unavailable. For Project 2, a subset (-20) of the proteins screened in
humans will be analyzed in mice exposed to cigarette smoke, lipopolysaccharide, CCI4 or paraquat. The
mouse data will identify markers that show selectivity for cigarette smoke exposure. The data for known
markers will also provide baseline information for comparison with novel biomarkers such as nitrated
proteins identified in this U54 program. Since the ELISA microarray format is a highly efficient system for
evaluating multiple affinity reagents, once we have identified the best candidate biomarkers of exposure, we
will screen over 500 human plasma samples using the most promising markers identified so far. Since the
on-site multiplexed sensor that will be developed in Project #3 is limited to 4 or 5 assays, these ELISA
microarray tests are essential to winnow down the number of candidate biomarkers and thereby identify the
most useful set of proteins for this instrument. Furthermore, since ELISA analyses are routinely used as a
quantitative clinical test, any ELISA's we develop can be directly translated to a standard clinical test.
Therefore, this core will facilitate the develop of routine clinical tests and of a on-site sensor for evaluating
exposure to environmental stimuli such as side-stream cigarette smoke.
氧化应激和炎症反应增加是暴露在环境中的常见后果
探员们。有许多假定的环境侮辱蛋白质标记物,尽管有限
了解这些蛋白质在监测人体低剂量暴露中的作用。除了……之外
假定的蛋白质标记,项目1和2中提出的蛋白质组和DNA微阵列分析是
预计将确定暴露在侧流烟雾中的新的候选生物标志物。这样做的目的是
ELISA微阵列的核心是评估候选蛋白质生物标志物的有用性
暴露在环境中。对于项目1,我们将在-120个人体血浆样本中筛选-50个蛋白质,以
识别因吸烟而改变的蛋白质。尽管这些分析中的大多数都将是
使用商业试剂,该核心还将开发最多10个生物标志物的夹心ELISAs
无法进行商业检测的产品。对于项目2,筛选到的蛋白质子集(-20)
人类将在暴露于香烟烟雾、脂多糖、CCI4或百草枯的小鼠身上进行分析。这个
鼠标数据将识别显示香烟烟雾暴露的选择性的标记。已知的数据
标记物还将提供基线信息,用于与硝化等新型生物标记物进行比较
在这个U54计划中确定的蛋白质。由于ELISA微阵列格式是一种高效的系统
评估多种亲和试剂,一旦我们确定了暴露的最佳候选生物标记物,我们
将使用到目前为止发现的最有希望的标记物来筛选500多个人类血浆样本。自.以来
将在项目#3中开发的现场多路传感器仅限于4到5次检测,这些酶联免疫吸附试验
微阵列测试对于筛选候选生物标志物的数量至关重要,从而识别
对这台仪器最有用的一组蛋白质。此外,由于酶联免疫分析通常被用作
定量临床试验,我们开发的任何一种ELISA都可以直接转化为标准的临床试验。
因此,这一核心将促进常规临床测试和现场评估传感器的开发。
暴露在环境刺激下,如侧流香烟烟雾。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD C ZANGAR其他文献
RICHARD C ZANGAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD C ZANGAR', 18)}}的其他基金
High-Throughput Evaluation of Breast Cancer Markers
乳腺癌标志物的高通量评估
- 批准号:
7492080 - 财政年份:2005
- 资助金额:
$ 11.55万 - 项目类别:
High-Throughput Evaluation of Breast Cancer Markers
乳腺癌标志物的高通量评估
- 批准号:
7691927 - 财政年份:2005
- 资助金额:
$ 11.55万 - 项目类别:
High-Throughput Evaluation of Breast Cancer Markers
乳腺癌标志物的高通量评估
- 批准号:
7668503 - 财政年份:2005
- 资助金额:
$ 11.55万 - 项目类别:
High-Throughput Evaluation of Breast Cancer Markers
乳腺癌标志物的高通量评估
- 批准号:
7002571 - 财政年份:2005
- 资助金额:
$ 11.55万 - 项目类别:
High-Throughput Evaluation of Breast Cancer Markers
乳腺癌标志物的高通量评估
- 批准号:
7274723 - 财政年份:2005
- 资助金额:
$ 11.55万 - 项目类别:
High-Throughput Evaluation of Breast Cancer Markers
乳腺癌标志物的高通量评估
- 批准号:
7126378 - 财政年份:2005
- 资助金额:
$ 11.55万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 11.55万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 11.55万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 11.55万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 11.55万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 11.55万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 11.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 11.55万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 11.55万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 11.55万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 11.55万 - 项目类别:
Standard Grant